没有迹象表明体重增加相关的DNA甲基化变化在精神性厌食症患者
Luisa Sophie Rajcsanyi1,2,3,4, Miriam Kesselmeier5, Christopher Schröder6,7
1Section of Molecular Genetics in Mental Disorders, University Hospital Essen, University of Duisburg-Essen, Virchowstr 174, 45147, Essen, Germany. luisa.rajcsanyi@uk-essen.de.
Scientific reports
|August 7, 2025
概括
这项研究没有发现任何证据表明在精神性厌食症 (AN) 患者的NR1H3基因位点发生了DNA甲基化变化. 在住院治疗期间体重增加并没有改变研究细胞中的甲基化模式.
科学领域:
- 遗传学 是一个遗传学.
- 精神病学是一个精神病学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 神经性厌食症 (AN) 是一种严重的精神障碍,其特点是体重明显低.
- 异常的DNA甲基化模式与人体体重的复杂调节有关.
- 以前的研究表明,在AN中的NR1H3基因位点发生了低甲基化,这需要进一步调查.
研究的目的:
- 复制NR1H3基因位点低甲基化在女性AN患者的独立队列中的发现.
- 用全基因组双硫酸盐测序来确定与AN患者显著体重增加相关的DNA甲基化变化.
- 探索在AN治疗重量恢复期间DNA甲基化中的动态变化.
主要方法:
- 复制研究涉及189名女性AN患者和67名健康对照,以评估NR1H3甲基化.
- 在体重增加之前和之后,从三个AN患者的CD14+细胞上进行全基因组双硫酸盐测序 (WGBS).
- 分析使用甲基化检测工具 (驼,甲) 和深度二硫酸盐测序进行验证.
主要成果:
- 在复制队列中的NR1H3位点的15个CpG位点中没有观察到显著的低甲基化.
- 微妙的甲基化差异仅在降低分析值时才被检测到,并且这些差异没有得到一致的证实.
- 技术复制未能在体重增加的AN患者中验证已识别的差异甲基化区域 (DMR).
结论:
- 该研究无法证实NR1H3在神经性厌食症患者中的低甲基化.
- 在体重增加后入院和出院期间,在AN患者中没有发现显著的DNA甲基化差异.
- 这些发现表明NR1H3甲基化可能不是AN或其治疗诱导的体重变化的可靠生物标志物.
相关概念视频
Anorexia Nervosa
191
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
191
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Genomic Imprinting and Inheritance
35.3K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.3K
Histone Modification
14.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.0K
Bulimia Nervosa
194
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
194
Phase II Reactions: Methylation Reactions
346
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
346


